In diabetes and obesity, increased levels of IL-6 and TNF-α have been demonstrated, whereas the serum levels of IL-6 and CRP have been shown to predict the future occurrence of diabetes mellitus type 2. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.